Department of Pathology
Lauren Ritterhouse is interested in the translation of emerging molecular biomarkers into the clinical laboratory, including those evaluating hematologic malignancies and circulating tumor DNA, as well as solid tumor mutational signature profiling. Additional research interests include the correlation between morphological and molecular findings, as well as the incorporation of molecular diagnostics into tumor classification.
Her research has been published in Modern Pathology, Journal of Thoracic Oncology, Journal of Clinical Investigation (JCI) Insight, Thyroid, JAMA Oncology, Cancer Discovery, American Journal of Surgical Pathology, OncoImmunology, and Oncotarget. She has also presented work at annual meetings of the United States and Canadian Academy of Pathology, the Association for Molecular Pathology, the Precision Medicine World Conference, and the American Society of Clinical Oncology.
Ritterhouse holds a BS in zoology/biomedical sciences summa cum laude from the University of Oklahoma and an MD and PhD from the University of Oklahoma College of Medicine. She completed a residency in anatomic pathology and a fellowship in molecular genetic pathology at Brigham and Women’s Hospital, Harvard Medical School.